Navigation Links
Annual Shareholders Meeting to Be Held May 5, 2008 at the University Club in St. Paul, MN
Date:4/15/2008

SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it will hold its annual shareholders meeting at 9:00 AM on May 5, 2008 at the University Club in St. Paul, MN.

Shareholders who held SpectraScience stock as of the close of business on March 31, 2008 and those who hold a valid proxy for the meeting are entitled to attend in person.

Jim Hitchin, CEO of SpectraScience, Inc. said, "I look forward to meeting with our shareholders to talk about our recent historical results and our plans for the future."

Additional information, including details of the business to be conducted at the annual meeting, is included in the Company's Notice of Annual Meeting of Shareholders and Proxy Statement, which has been filed with the Securities and Exchange Commission and mailed to all shareholders of record.

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-KSB and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-KSB and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures an
'/>"/>

SOURCE SpectraScience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cedar Point to Host 17th Annual Red Cross Miniature Golf Event
2. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
3. Otter Tail Corporation Holds 2008 Annual Meeting: Shareholders Elect Directors; Board Declares Quarterly Dividend
4. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
5. Northwest Hospital & Medical Center Hosts Health & Wellness Pavilion At Second Annual King 5 Healthy Living Expo
6. European Society of Human Reproduction & Embryology 24th annual meeting
7. Media advisory - Neurochems Annual and Special Meeting of Shareholders April 15, 2008
8. Neurochem Annual and Special Meeting of shareholders
9. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
10. China Medical Technologies to Announce 4QFY2007 Financial Results, Declare Annual Cash Dividend and Provide FY2008 Annual Targets on June 12, 2008
11. HealthMEDX Hosts Annual User Group Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... by researchers from the Medical College of Wisconsin, in ... pain and other sickle cell disease complications in children. ... providers and patients were also identified. The study ... of pediatrics at the Medical College and Children,s Research ... presented at the American Society of Hematology meeting Dec. ...
(Date:12/6/2009)... ON. Dec. 6, 2009 A new study provides ... known as venous thromboembolism (VTE). , The condition ... every year, and occurs when an abnormal clot forms ... causing pain and swelling. In some cases, the clot ... through the heart to the lungs, causing a potentially ...
(Date:12/5/2009)... ORLEANSA new three-drug combination has shown in a phase ... effective regimen" in the treatment of patients newly diagnosed ... in bone marrow, say researchers from Dana-Farber Cancer Institute. ... of the 66 patients treated with the drug combination ... "very good partial response rate" in the phase 2 ...
(Date:12/5/2009)... Youngest Babies, This Type of Blood Cancer Is Most ... 5 Pediatric oncologists have identified specific genes, dubbed ... an often-fatal form of leukemia in infants. By more ... predict which infants may benefit from particular treatments. ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... of Britain to highlight the risks of male obesity , ... (PRWEB) ... the country to raise awareness of obesity and to encourage the British ... that many feel embarrassed about, such as bingo wings, wobbly bellies and ...
... ... 2009, VIRGINIA BEACH, Va. Oct. 22, 2008 AMERIGROUP,Corporation (NYSE: ... third,quarter of 2008 was $39.4 million, or $0.74 per diluted share, ... of 2007, a 26.2%,increase., The Company is increasing and narrowing ...
... ),announced today that the jury in the case of ... in Hackensack (Bergen County), found in favor of,the plaintiff ... reviewing,its post-trial options., "We respectfully disagree with the ... which demonstrated that Mrs. Stribling,s,health problems were caused by ...
... and,Chair Emeritus of the University of Louisville,s Department of ... Research (FBR) today announced its board of governors has,unanimously ... the board. Dr.,Polk succeeds the late Dr. Michael E. ... "I am honored to represent the Foundation for Biomedical ...
... of Providing Quality Long Term Care by,$4.2 Billion ... new Eljay, LLC,analysis of Medicaid financing, which was ... projects that Medicaid underfunds the actual,cost of providing ... billion -- with,New York, Illinois, Ohio, Pennsylvania, New ...
... feat could shed light on how cancer develops , , WEDNESDAY, ... stem cell, scientists say they have grown entire prostates in ... of a genetic signature distinguishing stem cells from other types ... issue of Nature . , This information still has ...
Other Medicine News:Health News:Virgin Active Says Leave the Cleavage to the Girls 2Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 2Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 3Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 4Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 5Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 6Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 7Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 8Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 9Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 10Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 11Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 12Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 13Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 14Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 15Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 16Health News:AMERIGROUP Corporation Earns $0.74 Per Diluted Share 17Health News:The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors 2Health News:New National Medicaid Study Underscores Importance of Including State Relief in Stimulus Plan 2Health News:New National Medicaid Study Underscores Importance of Including State Relief in Stimulus Plan 3Health News:New Prostrates Grown From Single Stem Cell 2
(Date:12/4/2009)... Dec. 4 Chemistry World recently highlighted a ... and Manufacturers of America ( PhRMA ) that identifies ... related conditions. ,, The report found that the ... These drugs are either in human clinical trials or awaiting ...
(Date:12/4/2009)... SAN DIEGO, Calif., Dec. 4 Suneva Medical, a ... of Philip Ranker as Vice President and Chief Financial ... all Suneva Medical,s general and administrative functions including finance, ... will also serve on the Company,s senior management team. ...
(Date:12/4/2009)... TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced ... Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected ... across the country. The grand prize is an in-person meeting ... type 1 diabetes like Nick, are: Caleb, age 6, from ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Kendall Jackson Hosts Five Month Online Charity Auction Featuring Collectibles From Champion Thoroughbred 50774 1Kendall Jackson Hosts Five Month Online Charity Auction Featuring Collectibles From Champion Thoroughbred 50774 2Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 1Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 2Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year 50773 3Dr John Mach Appointed Chief Medical Officer at XLHealth 50771 1Dr John Mach Appointed Chief Medical Officer at XLHealth 50771 2
... FRANCISCO, Calif., March 25 Poniard Pharmaceuticals, Inc. (Nasdaq: ... oncology, today announced that it has reached its enrollment ... Picoplatin Efficacy After Relapse) trial. This global, pivotal Phase ... picoplatin in patients with recurrent small cell lung cancer ...
... 25 Amicus Therapeutics (Nasdaq: FOLD ) today ... Patent No. 7,501,439, titled "Tartrate Salt of Isofagomine and Methods ... of isofagomine, the active ingredient in the Company,s investigational drug ... Gaucher disease. The patent will expire in 2027. ...
Other Medicine Technology:Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 2Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 3Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer 4Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 2Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: